Catalyst Wire Dossier Catalyst Wire Dossier

Amitiza

lubiprostone · Takeda Pharmaceutical Company
Drug timelines are a Plus or Pro feature.

17 regulatory and trial events tracked for Amitiza, covering 2011-12-12 to 2026-02-12. Get the full timeline:

Most recent: Clinical Trial Update: Lubiprostone Combined With Maintenance Therapy for Prevention of Postoperative Recurrence in Peritoneal Metastatic Colorectal Cancer [Phase 2]

See pricing